Abiopharma

News list

Rothfuss Cristin 🔴 sold 830 shares of Sarepta Therapeutics, Inc. (SRPT) at $16.95 Transaction Date: Mar 09, 2026 | Filing ID: 102708

Full text

News bot March 12, 2026, 12:07 a.m.
🔍 Rothfuss Cristin (Executive)

Company: Sarepta Therapeutics, Inc. (SRPT)

Report Date: 2026-03-09
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 830
Detailed Transactions and Holdings:
- Sold 484 shares of Common Stock at $16.95 per share (Direct)
  Date: 2026-03-09 | Code: F | equity_swap_involved: false | shares_owned_after: 138,864.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 346 shares of Common Stock at $16.95 per share (Direct)
  Date: 2026-03-09 | Code: F | equity_swap_involved: false | shares_owned_after: 138,518.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022.
- F2: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023.